Skip to main content

Table 2 Cardiovascular risk factors at baseline, 6 months and 1 year

From: Long-term effects on cardiovascular risk of a structured multidisciplinary lifestyle program in clinical practice

Total parameter Baseline n = 100 6 months n = 88 1 year n = 80 ANOVA p-value
Weight (kg) 93.4 (19.2) 92.5 (19.5)a 92.6 (19.8) 0.056
BMI (kg/m2) 31.6 (28.3 to 35.5) 31.4 (28.1 to 35.3)a 31.1 (28.0 to 34.9) < 0.001
Waist Circumference (cm) 108.4 (15.0) 106.8 (15.3)a 105.9 (15.1)a, b < 0.001
Men (cm) 113.5 (14.6) 112.4 (14.3) 111.7 (13.2)a 0.099
Women (cm) 105.5 (14.6) 103.7a(15.1) 102.6a,b(15.1) 0.001
Systolic BP (mmHg) 135 (120 to 149) 130 (120 to 140)a 130 (120 to 140)a < 0.001
With BP lowering medication* (n = 66) 140 (125 to 150) 130 (120 to 140) 130 (120 to 140)a 0.002
No medication (n = 34) 130 (120 to 140) 120 (119 to 140) 130 (118 to 136) 0.027
Diastolic BP (mmHg) 85 (80 to 90) 80 (75 to 90)a 80 (75to 85)a < 0.001
With BP lowering medication* (n = 66) 85 (80 to 90) 80 (75 to 90) 80 (79 to 85)a 0.006
No medication (n = 34) 80 (80 to 90) 80 (80 to 85) 80 (70 to 90) 0.018
Heart rate (bpm) 66 (60 to 76) 68 (62 to 80) 64 (60 to 76) 0.087
Total Cholesterol (mmol/l) 5.1 (1.1) 4.9 (1.1)a 4.9 (1.0) 0.019
With Statins (n = 36) 4.5 (0.9) 4.3 (0.8) 4.4 (0.9) 0.151
No statins (n = 64) 5.4 (1.1) 5.2 (1.1) 5.1 (1.0) 0.081
LDL (mmol/l) 3.1 (2.4 to 3.9) 2.8 (2.3 to 3.9) 2.8 (2.2 to 3.7) 0.065
With Statins (n = 36) 2.6 (2.1 to 3.1) 2.4 (2.1 to 2.7) 2.4 (2.0 to 2.7) 0.342
No statins (n = 64) 3.6 (2.8 to 4.2) 3.2(2.6 to 4.1) 3.2 (2.6 to 4.0) 0.181
HDL (mmol/l) 1.3 (1.0 to 1.5) 1.2 (1.0 to 1.5) 1.4 (1.0 to 1.6) 0.227
Men (n = 36) 1.1 (0.4) 1.1 (0.5) 1.2 (0.6) 0.260
Women (n = 64) 1.4 (0.4) 1.4 (0.4) 1.4 (0.4) 0.633
Triglycerides (mmol/l) 1.2 (0.9 to 1.6) 1.3 (0.9 to 1.6) 1.2 (0.8 to 1.8) 0.376
  1. Values are presented as mean (SD) or median (Q1 to Q3)
  2. aSignificantly different from baseline, p < 0.05
  3. bSignificantly different from 6 months, p < 0.05
  4. BMI Body Mass Index, BP Blood pressure, LDL Low density lipoprotein, HDL High density lipoprotein